Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

Healthcare Biotechnology
"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

BioExx Specialty Proteins Ltd
Bullboard Posts
User Avatar Image
(0)
•••
Comment by CurlyMickon Mar 01, 2012 11:33am
346 Views
Post# 19611119

RE: both Cormack and Raymond James

RE: both Cormack and Raymond James

I was impressed by Chris Scnarr. Half of the analysts asked good questions related to scalability, related capital required, etc.  The other half of the analysts must have been fairly junior asking naive questions that Chris had to dissuade because they were wildly speculative but looking for numbers. 

 

IMHO, hopefully some real time analysts (ok IMHO most suck) or at least ones that have some influence will be attracted to the next call. 

 

There will be scalability in the share price too. You can't say enough about Chris's committment to keep us informed of every step along the way. It's all related. 

 

Curly

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities